These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30179316)

  • 1. Impact of dose and duration of corticosteroid on the risk of hepatitis flare in patients with chronic hepatitis B.
    Wong GL; Yuen BW; Chan HL; Tse YK; Yip TC; Lam KL; Lui GC; Wong VW
    Liver Int; 2019 Feb; 39(2):271-279. PubMed ID: 30179316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposure.
    Wong GL; Wong VW; Yuen BW; Tse YK; Yip TC; Luk HW; Lui GC; Chan HL
    J Hepatol; 2020 Jan; 72(1):57-66. PubMed ID: 31499132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of alanine aminotransferase flare in patients with previous hepatitis B virus exposure on biological modifier therapies-A population-based study.
    Ho JCL; Mak JWY; Yip TCF; Lam HM; Cheng TY; Lam TO; Tam LS; Law MF; Cheung CKM; Ng SC; Wong VWS; Wong GLH
    Liver Int; 2023 Mar; 43(3):588-598. PubMed ID: 36516362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B.
    Seo HY; Lee HA; Ko SY; Wang JH; Kim JH; Choe WH; Kwon SY
    Clin Mol Hepatol; 2017 Jun; 23(2):154-159. PubMed ID: 28479588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B.
    Lee HA; Seo YS; Park SW; Park SJ; Kim TH; Suh SJ; Jung YK; Kim JH; An H; Yim HJ; Yeon JE; Byun KS; Um SH
    Clin Mol Hepatol; 2016 Sep; 22(3):382-389. PubMed ID: 27729633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics of hepatic flare and efficacy of antiviral therapy in pregnant women with chronic hepatitis B virus infection].
    Ding Y; Sheng QJ; Zhang C; Wu YY; Yuan SY; Xia TT; An ZY; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):106-111. PubMed ID: 30818914
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
    Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
    World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation.
    Uribe LA; Nguyen N; Kim L; Trinh HN; Wong C; Wong C; Nguyen LH; Nguyen MH
    Dig Dis Sci; 2016 Feb; 61(2):618-25. PubMed ID: 26660679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of Corticosteroid Treatment in Rheumatologic Patients With Markers of Hepatitis B Viral Infection: Pilot Evaluation Study.
    Braun-Moscovici Y; Braun M; Saadi T; Markovits D; Nahir MA; Balbir-Gurman A
    J Clin Rheumatol; 2016 Oct; 22(7):364-8. PubMed ID: 27660934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy.
    Hsu YC; Mo LR; Chang CY; Wu MS; Yang TH; Kao JH; Chen CC; Tseng CH; Tai CM; Lin CW; Wu CY; Lin JT
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1512-1519. PubMed ID: 28122151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of overall survival between antiviral-induced viral suppression and inactive phase chronic hepatitis B patients.
    Cho YY; Lee JH; Chang Y; Nam JY; Cho H; Lee DH; Cho EJ; Lee DH; Yu SJ; Lee JM; Kim YJ; Yoon JH
    J Viral Hepat; 2018 Oct; 25(10):1161-1171. PubMed ID: 29741286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy.
    Flink HJ; Sprengers D; Hansen BE; van Zonneveld M; de Man RA; Schalm SW; Janssen HL;
    Gut; 2005 Nov; 54(11):1604-9. PubMed ID: 15923670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative Therapies for Chronic Hepatitis B Patients With Partial Virological Response to Standard Entecavir Monotherapy.
    Chaung KT; O'Brien C; Ha NB; Nguyen NH; Trinh HN; Nguyen MH
    J Clin Gastroenterol; 2016 Apr; 50(4):338-44. PubMed ID: 26646801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis.
    An J; Shim JH; Kim SO; Choi J; Kim SW; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    J Med Virol; 2016 Sep; 88(9):1576-86. PubMed ID: 26945543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B.
    Chang CY; Aziz N; Poongkunran M; Javaid A; Trinh HN; Lau D; Nguyen MH
    Am J Gastroenterol; 2016 Oct; 111(10):1410-1415. PubMed ID: 27456990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum alanine aminotransferase flares during interferon treatment of chronic hepatitis B: is sustained clearance of HBV DNA dependent on levels of pretreatment viremia?
    Nair S; Perrillo RP
    Hepatology; 2001 Nov; 34(5):1021-6. PubMed ID: 11679974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis B.
    Yasui S; Fujiwara K; Nakamura M; Miyamura T; Yonemitsu Y; Mikata R; Arai M; Kanda T; Imazeki F; Oda S; Yokosuka O
    J Viral Hepat; 2015 Feb; 22(2):94-102. PubMed ID: 24750410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and risk factors of hepatitis B flares in chronic hepatitis B patients receiving glucocorticoid pulse therapy.
    Lin YC; Lee SW; Yeh HZ; Chang CS; Yang SS
    Int J Clin Pharm; 2018 Feb; 40(1):169-174. PubMed ID: 29322472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Hepatitis B Increases Liver-Related Mortality of Patients With Acute Hepatitis E: A Territorywide Cohort Study From 2000 to 2016.
    Lai JC; Wong GL; Yip TC; Tse YK; Lam KL; Lui GC; Chan HL; Wong VW
    Clin Infect Dis; 2018 Sep; 67(8):1278-1284. PubMed ID: 30265321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.